EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against Plasmodium falciparum

Savannah J Watson, Mariëtte E van der Watt, Anjo Theron, Janette Reader, Sizwe Tshabalala, Erica Erlank, Lizette L Koekemoer, Mariska Naude, Marianna Stampolaki, Feyisola Adewole, Katie Sadowska, Pilar Pérez-Lozano iD und 12 weitere

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Savannah J Watson und 23 weiteren Autor:innen. Beteiligte Einrichtung: Next Generation Health, Council for Scientific and Industrial Research, Pretoria 0001, South Africa. Hauptthemen laut MEDLINE: Plasmodium falciparum, Antimalarials, Antitubercular Agents, Adamantane. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation, Medicines for Malaria Venture, National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumAntimalarialsAntitubercular AgentsAdamantaneHumansStructure-Activity RelationshipAnimalsMalaria, FalciparumInhibitory Concentration 50Ethylenediamines

Stichwörter der Autor:innen

Plasmodium falciparumSQ109antimalarialmultistagetransmission-blocking

Substanzen

AntimalarialsAntitubercular AgentsAdamantaneN-geranyl-N'-(2-adamantyl)ethane-1,2-diamineEthylenediamines

Autor:innen und Institutionen

  • Next Generation Health, Council for Scientific and Industrial Research, Pretoria 0001, South Africa.
  • Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Services, Wits Research Institute for Malaria, Faculty of Health Sciences, University o…
  • Laboratory of Medicinal Chemistry, Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupolis-Zografou, 15771 Athens, Greece.
  • Department of Biological, Physical and Health Sciences, College of Science, Health & Pharmacy, Roosevelt University, 425 South Wabash Avenue, Chicago, Illinois 60605, United States.
  • Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona 08028, Spain.
  • Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Unive…

ORCID-Profile: Pilar Pérez-Lozano, Santiago Vázquez, Jihee Ko, Ben Mazurek, Satish R Malwal, Kelly Chibale, Antonios Kolocouris, Eric Oldfield, Lyn-Marié Birkholtz

Förderung

  • Bill and Melinda Gates Foundation
  • Medicines for Malaria Venture
  • National Research Foundation
  • South African Medical Research Council

Zitieren

APA

Watson, S. J., van der Watt, M. E., Theron, A., Reader, J., Tshabalala, S., Erlank, E., Koekemoer, L. L., Naude, M., Stampolaki, M., Adewole, F., Sadowska, K., Pérez-Lozano, P., Turcu, A. L., Vázquez, S., Ko, J., Mazurek, B., Singh, D., Malwal, S. R., Njoroge, M., …, & Birkholtz, L. M. (2024). The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against Plasmodium falciparum. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00461

Vancouver

Watson SJ, van der Watt ME, Theron A, Reader J, Tshabalala S, Erlank E, et al. The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against Plasmodium falciparum. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00461

BibTeX
@article{Watson2024,
  author = {Watson, Savannah J and van der Watt, Mariëtte E and Theron, Anjo and Reader, Janette and Tshabalala, Sizwe and Erlank, Erica and Koekemoer, Lizette L and Naude, Mariska and Stampolaki, Marianna and Adewole, Feyisola and Sadowska, Katie and Pérez-Lozano, Pilar and Turcu, Andreea L and Vázquez, Santiago and Ko, Jihee and Mazurek, Ben and Singh, Davinder and Malwal, Satish R and Njoroge, Mathew and Chibale, Kelly and Onajole, Oluseye K and Kolocouris, Antonios and Oldfield, Eric and Birkholtz, Lyn-Marié},
  title = {The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against Plasmodium falciparum},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00461}
}
Kostenlos starten →